Femasys Inc. Common Stock (FEMY) Stock Price

FEMYStock

$1.65−88.93%52W

Market Cap$13.82M

P/E—

PEG Ratio—

Div yield—

Beta-2.30

FEMY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-90.72%

Price vs S&P 500 (4W)-33.46%

VGM Score33.64

Book Value / Share (Quarterly)$1.33

P/TBV (Annual)5.98x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)23.75%

Cash Flow / Share (Quarterly)$-6.02

Price vs S&P 500 (YTD)-97.60%

Gross Margin (TTM)60.95%

Net Profit Margin (TTM)-511.77%

EPS (TTM)$-4.41

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$-4.41

Revenue Growth (5Y)17.13%

EPS (Annual)$-9.42

ROI (Annual)-205.87%

Gross Margin (Annual)61.96%

Net Profit Margin (5Y Avg)-975.33%

Cash / Share (Quarterly)$0.48

Revenue Growth QoQ (YoY)-18.92%

ROA (Last FY)-89.88%

Revenue Growth TTM (YoY)21.86%

EBITD / Share (TTM)$-5.53

ROE (5Y Avg)-262.99%

Operating Margin (TTM)-763.90%

Cash Flow / Share (Annual)$-6.48

P/B Ratio3.43x

P/B Ratio (Quarterly)3.13x

Net Income / Employee (Annual)$-365,300

EV / Revenue (TTM)6.91x

Net Interest Coverage (TTM)-9.41x

ROA (TTM)-71.54%

EPS Incl Extra (Annual)$-9.42

Current Ratio (Annual)4.53x

Quick Ratio (Quarterly)0.55x

3-Month Avg Trading Volume0.53M

52-Week Price Return-88.93%

Revenue / Employee (TTM)$45,100

Tangible BV / Share (Quarterly)$1.29

P/S Ratio (Annual)6.03x

Asset Turnover (Annual)0.11x

52-Week High$22.20

Operating Margin (5Y Avg)-975.52%

EPS Excl Extra (Annual)$-9.42

CapEx CAGR (5Y)83.85%

26-Week Price Return-80.81%

Quick Ratio (Annual)2.95x

13-Week Price Return-45.18%

Total Debt / Equity (Annual)0.54x

Current Ratio (Quarterly)2.14x

Enterprise Value$15.90M

Revenue / Share Growth (5Y)67.33%

Asset Turnover (TTM)0.14x

Revenue / Employee (Annual)$45,000

Inventory Turnover (Annual)0.20x

Pretax Margin (Annual)-812.21%

Cash / Share (Annual)$3.11

3-Month Return Std Dev110.79%

Gross Margin (5Y Avg)64.90%

Net Income / Employee (TTM)$-230,700

ROE (Last FY)-317.38%

Net Interest Coverage (Annual)-9.07x

EPS Basic Excl Extra (Annual)$-9.42

Receivables Turnover (TTM)11.34x

Total Debt / Equity (Quarterly)0.87x

EPS Incl Extra (TTM)$-4.41

Receivables Turnover (Annual)4.15x

ROI (TTM)-122.06%

P/S Ratio (TTM)6.01x

Pretax Margin (5Y Avg)-974.95%

Revenue / Share (Annual)$1.16

Tangible BV / Share (Annual)$1.92

Price vs S&P 500 (52W)-104.47%

Year-to-Date Return-85.68%

5-Day Price Return-5.71%

EPS Normalized (Annual)$-9.42

ROA (5Y Avg)-77.24%

Net Profit Margin (Annual)-812.27%

Month-to-Date Return-23.61%

Cash Flow / Share (TTM)$-0.94

EBITD / Share (Annual)$-8.72

Operating Margin (Annual)-766.96%

LT Debt / Equity (Annual)0.54x

ROI (5Y Avg)-122.54%

LT Debt / Equity (Quarterly)0.87x

EPS Basic Excl Extra (TTM)$-4.41

P/TBV (Quarterly)3.22x

P/B Ratio (Annual)5.84x

Inventory Turnover (TTM)0.16x

Pretax Margin (TTM)-511.49%

Book Value / Share (Annual)$1.97

Price vs S&P 500 (13W)-47.87%

Beta-2.30x

Revenue / Share (TTM)$0.69

ROE (TTM)-216.46%

52-Week Low$1.46

vGradeD

gGradeC

mGradeF

vgmGradeD

FEMY Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$1.40	-$1.10	+21.17%(+$0.30)
Q1 2026	May 8, 2026	-$1.80	-$1.46	+18.89%(+$0.34)
Q4 2025	Mar 31, 2026	-$1.80	-$0.20	+88.89%(+$1.60)
Q3 2025	Nov 14, 2025	-$2.60	-$2.00	+23.08%(+$0.60)
Q2 2025	Aug 8, 2025	-$3.60	-$3.20	+11.11%(+$0.40)

FEMY Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
FEMYFemasys Inc. Common Stock	D	C	F	6.0x	17.1%	61.0%	-763.9%	$1.65
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Femasys Inc. Common Stock

Femasys develops minimally invasive medical devices for women's healthcare, offering office-based solutions for infertility treatment, contraception, and diagnostic procedures. Its product portfolio includes FemaSeed for intratubal insemination, FemVue for fallopian tube assessment, FemBloc for permanent contraception (in development), FemCerv for cervical cancer diagnosis, and FemCath and FemChec. The company generates revenue primarily from the United States market with additional international sales.